Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US7026292

Title:Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
Inventors:Lee, John C.; San Antonio, TX, USA
Yeh, Lee-Chuan C.; San Antonio, TX, USA
Summary:Described herein are methods for increasing tissue formation with a mixture of morphogenic protein and a stimulatory factor. The invention relates to pharmaceutical compositions comprising a morphogenic protein stimulatory factor (MPSF) for improving the tissue inductive activity of morphogenic proteins, particularly those belonging to the BMP protein family. Further disclosed are methods for improving the tissue inductive activity of a morphogenic protein in a mammal using such compositions. Implantable morphogenic devices are described, which consist of a morphogenic protein and a MPSF disposed within a carrier, that are capable of inducing tissue formation in allogeneic and xenogeneic implants. Further disclosed are methods for inducing local tissue formation from a progenitor cell in a mammal using those devices, and for accelerating allograft repair in a mammal using such morphogenic devices. Also described is a prosthetic device comprising a prosthesis coated with a morphogenic protein and a MPSF, and a method for promoting the in vivo integration of an implantable prosthetic device to enhance the bond strength between the prosthesis and the existing target tissue at the joining site. Therapeutic applications are provided in the pharmaceutical treatment of mammalian tissue degenerative conditions, and in the repair of bone or cartilage defects.
Abstract:
US Patent Website:Click Here for Full Text of Patent
Title Number:US7026292
Application Number:US1999000287500
Date Filed:07/04/1999
Date Published:11/04/2006
Assignee:Stryker Corporation, Kalamazoo, MI, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021